by Patient Voice Initiative | Sep 3, 2019 | C, Glossary
A process to find valid and relevant evidence or methods in a systematic review or HTA. Evidence is considered using a system of agreed rules to check its quality and decide if it should be included in the HTA or not. For example, evidence from a particular study may... by Patient Voice Initiative | Sep 3, 2019 | C, Glossary
A study similar to a cost‐effectiveness analysis. The costs are measured in units of money and the benefits are stated in a value that reflects patient preferences (known as utilities), such as a quality‐adjusted life year. HTAI by Patient Voice Initiative | Sep 3, 2019 | C, Glossary
This analysis compares two or more drugs, devices, tests, or procedures to find out which provides more outcomes for the cost of treatment or which has the lowest cost for a given outcome. This means that the outcomes of all treatments being compared must be measured... by Patient Voice Initiative | Sep 3, 2019 | C, Glossary
The national peak body representing the interests of Australian healthcare consumers. CHF works to achieve safe, quality, timely healthcare for all Australians, supported by accessible health information and systems. by Patient Voice Initiative | Sep 3, 2019 | C, Glossary
The medicine or treatment currently being used which the new medicine or treatment is being compared to in an assessment. If the new medicine or treatment is recommended for the PBS the comparator will usually be replaced by the new treatment.